Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,255 | -19,773 | -15,769 | -12,578 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 597 | N/A |
| Accounts payable and accrued liabilities | -119 | 472 | 211 | 806 | N/A |
| Other Working Capital | -1,238 | 3,086 | 353 | 1,126 | N/A |
| Other Operating Activity | 8,907 | 3,144 | 3,109 | 5,927 | 0 |
| Operating Cash Flow | $-15,705 | $-13,071 | $-12,096 | $-4,123 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 7,369 | N/A |
| Debt Repayment | N/A | N/A | N/A | 63 | N/A |
| Common Stock Issued | 18,972 | 11,418 | 14,443 | 6,281 | N/A |
| Other Financing Activity | -795 | -2,148 | -1,966 | 322 | 0 |
| Financing Cash Flow | $18,177 | $9,271 | $12,477 | $14,034 | $N/A |
| Exchange Rate Effect | -22 | 0 | -4 | 0 | N/A |
| Beginning Cash Position | 7,151 | 10,951 | 10,574 | 664 | N/A |
| End Cash Position | 9,601 | 7,151 | 10,951 | 10,574 | N/A |
| Net Cash Flow | $2,451 | $-3,800 | $377 | $9,911 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,705 | -13,071 | -12,096 | -4,123 | N/A |
| Free Cash Flow | -15,705 | -13,071 | -12,096 | -4,123 | 0 |